TRDA Operating Cash Flow (Statement)
Entrada Therapeutics Inc · Operating Cash Flow (Statement)
TRDA Operating Cash Flow (Statement)
Latest reported-$32.46Mperiod ending
TRDA Quarterly Cash from Operations (-$6.65M → -$32.46M)
Quarterly operating cash flow (statement)
High-resolution chart · PNG
TRDA operating cash flow (statement) history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| -32,463,000 | |
| -41,695,000 | |
| -32,203,000 | |
| -28,313,000 | |
| -29,489,000 | |
| -38,507,000 | |
| -31,605,000 | |
| -24,266,000 | |
| 39,833,000 | |
| -25,519,000 | |
| -4,013,000 | |
| -24,492,000 | |
| -35,091,000 | |
| 203,399,000 | |
| -27,304,000 | |
| -27,482,000 | |
| -18,009,000 | |
| -20,991,000 | |
| -20,541,000 | |
| -14,075,000 | |
| -7,910,000 | |
| -8,336,000 | |
| -6,624,000 | |
| -5,645,000 | |
| -6,650,500 | |
| -6,650,500 |